Business
Aurobindo arm Lannett launches genericof GSK’s drug in U.S.
The launch marks the first product from Aurobindo Pharma’s inhalation pipeline to be commercialised in the U.S.
This story summarizes reporting from The Hindu. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.
Read full story on The Hindu →The Hindu31 Aug 2026, 02:35 pmUpdated 4h ago1 min readBusinessIndia
India — The Hindu
